Harbour BioMed
Latest round
- Series C
Last raised
- Jul 2020
Total raised
- $263M
Investors
- 18
About Harbour BioMed
Founded in 2016 and based in Shanghai, China, Harbour BioMed is a biotechnology company that focuses on developing therapeutics for the treatment of cancer. The company also offers transgenic mouse platforms including transgenic mouse platforms for human antibody discovery.
Who invested in Harbour BioMed
18 investors across 4 rounds
See all investors in Harbour BioMed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Harbour BioMed
Who invested in Harbour BioMed?
Harbour BioMed has 18 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Harbour BioMed raised?
Harbour BioMed has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Harbour BioMed last raise money?
Harbour BioMed's most recent round on record is a Series C, in Jul 2020.
What does Harbour BioMed do?
Founded in 2016 and based in Shanghai, China, Harbour BioMed is a biotechnology company that focuses on developing therapeutics for the treatment of cancer.
Where is Harbour BioMed headquartered?
Harbour BioMed is headquartered in Cambridge, US.
Which VCs invest in companies like Harbour BioMed?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Harbour BioMed's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Harbour BioMed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.